Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Cystic Fibrosis (CF) Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Global Cystic Fibrosis (CF) Diagnostics Market

 

By Test Type (Antenatal testing, Carrier testing, Sweat tests, CFTR-Related Metabolic Syndrome (CRMS), Newborn screening, Prenatal screening), by Product Type (Diagnostic Kits, Reagents, and Others) End User (Hospitals and Diagnostic Centers)and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Cystic Fibrosis (CF) Diagnostics market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Cystic Fibrosis (CF) Diagnostics Market

Cystic fibrosis (CF) is a chronic, genetic disease that causes persistent lung infections and limits the ability to breathe over time. Several mutations in the gene is responsible for Cystic fibrosis that encodes cystic fibrosis transmembrane conductance regulator (CFTR) protein. Patients with CF have inherited two copies of the defective CF gene — one copy from each parent. Both parents must have at least one copy of the defective gene. Currently there are approximately 70,000 people who are suffering from cystic fibrosis worldwide, according to the Cystic Fibrosis Foundation (CFF). Some of the popular methods of diagnosis are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests.

 

Market Dynamics: Cystic Fibrosis (CF) Diagnostics Market

According to Cystic Fibrosis Foundation, the incidence of these hereditary disorders is constantly growing. The nonprofit organizations are investing huge amount of funds to find various therapeutics for CF and to support the research & developmental activities. The major driver for the market is improved diagnostic technologies. Increase in investment and awareness about genetic diseases are aiding in development of diagnostic technologies, which will fuel the market growth. The high cost of the drugs and treatment may hamper the growth of the market.

 

Market Scope: Cystic Fibrosis (CF) Diagnostics Market

Cystic Fibrosis (CF) Diagnostics market is segmented based on the product type, test type

The market is segmented into the following based on test type:

  • Antenatal Testing
  • Carrier Testing
  • Sweat Tests
  • CFTR-Related Metabolic Syndrome (CRMS)
  • Newborn Screening
  • Prenatal Screening

The market is segmented into the following based on product type:

  • Diagnostic Kits
  • Reagents
  • Others

Based on the end user, the market is segmented into the following:

  • Hospital
  • Diagnostic centers

 

Market Summary: Cystic Fibrosis (CF) Diagnostics Market

The global cystic fibrosis diagnostics market is expected to witness tremendous growth. Novel diagnostic tools for cystic fibrosis are being developed. The scientists at Stanford University, have developed a DNA test for the accurate and comprehensive screening of newborns for cystic fibrosis. By this test the next-generation DNA sequencing can be identified and this test is considered to be less expensive and less time-consuming technology.

 

Regional Analysis:  Cystic Fibrosis (CF) Diagnostics Market

Geographically, global Cystic Fibrosis (CF) Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The higher incidence rate of cystic fibrosis is observed in North America. The median age of the person with cystic fibrosis is currently 33.4 years according cystic fibrosis foundation’s national patient registry. Followed by the North America is the European region which has more affected population with cystic fibrosis. Out of this affected population, 51.8% were adults and 48.2% were less than 18 years old. Whereas the birth prevalence of CF is higher in United Kingdom, Ireland, Romania, and Bulgaria. When it comes to the Asian region, the prevalence of cystic fibrosis is seen to be very low. The Middle East and Africa holds the lowest share in the market, especially countries in the African region

 

Competition Assessment: Cystic Fibrosis (CF) Diagnostics Market

Some of the players in the global Cystic Fibrosis (CF) Diagnostics market include:

  • Elucigene
  • Asper Biogene
  • ELITechGroup
  • Natera, Inc.
  • Randox Laboratories Ltd.
  • Luminex Corporation
  • Appolon Bioteck
  • Arazy Group
  • Illumina Inc.

 

Notable Market Developments: Cystic Fibrosis (CF) Diagnostics Market

  • In February 2018, Luminex’s xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM in Brazil.
  • In March 2017, Elucigene Diagnostics announced the official launch of new CF-Italia kit (CF1ITB1).
  • In April 2017, Elucigene Diagnostics partnered with Southern Cross Diagnostics in order to expand in Australia and New Zealand markets

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  1. Executive Summary
  2. Global Cystic Fibrosis (CF) Diagnostics Market Introduction
    • Global Cystic Fibrosis (CF) Diagnostics Market – Taxonomy
    • Global Cystic Fibrosis (CF) Diagnostics Market –Definitions
      • Test Type
      • Product Type
      • End User
  1. Global Cystic Fibrosis (CF) Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Cystic Fibrosis (CF) Diagnostics Market Dynamic Factors – Impact Analysis
    • Global Cystic Fibrosis (CF) Diagnostics Market – Competition Landscape
    • Epidemiology
  2. Global Cystic Fibrosis (CF) Diagnostics Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Cystic Fibrosis (CF) Diagnostics Market, By Test Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Antenatal Testing
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Carrier Testing
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Sweat Tests
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CFTR-Related Metabolic Syndrome (CRMS)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Newborn Screening
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prenatal Screening
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Diagnostic Kits
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Reagents
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Region, 2018 – 2024
  2. North America Cystic Fibrosis (CF) Diagnostics MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2018 – 2024
    • North America Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  3. Europe Cystic Fibrosis (CF) Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2018 – 2024
    • Europe Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  4. Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2018 – 2024
    • Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  5. Latin America Cystic Fibrosis (CF) Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2018 – 2024
    • Latin America Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  6. Middle East and Africa Cystic Fibrosis (CF) Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2018 – 2024
    • MEA Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Test Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Elucigene
      • Asper Biogene
      • ELITechGroup
      • Natera, Inc.
      • Randox Laboratories Ltd.
      • Luminex Corporation
      • Appolon Bioteck
      • Arazy Group
      • Illumina Inc.
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553